sellWeak cluster of 510b5-1 plan
BOBO DONALD E JR sold $492k of EW
CVP,Strategy/Corp Development at Edwards Lifesciences Corp. 6,500 shares at an average of $75.75, traded Feb 13, 2025, filed Feb 13, 2025.
Warning score
18Value
$492k
6,500 shares
Holdings after
46,936
-12% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001225208-25-001711, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 13, 2025 | MOption exercise Common Stock10b5-1 | +6,500 | $45.28 | $294k | 53,436 | Feb 13, 2025 |
| Feb 13, 2025 | SOpen-market sale Common Stock10b5-1 | -100 | $76.26 | $7,626 | 53,336 | Feb 13, 2025 |
| Feb 13, 2025 | SOpen-market sale Common Stock10b5-1 | -6,400 | $75.74 | $485k | 46,936 | Feb 13, 2025 |
| Feb 13, 2025 | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -6,500 | $0.00 | $0 | 19,000 | Feb 13, 2025 |
Related signals
Other insiders at Edwards Lifesciences Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 27Weak | sell 210b5-1 | EW Edwards Lifesciences Corp | Ullem Scott B. CVP, Chief Financial Officer | $797k | 11,250 | |
| 20Weak | sell 410b5-1 | EW Edwards Lifesciences Corp | BOBO DONALD E JR CVP,Strategy/Corp Development | $646k | 9,500 | |
| 0Weak | sell 410b5-1 | EW Edwards Lifesciences Corp | Lippis Daniel J. CVP, JAPAC | $28k | 400 | |
| 22Weak | sell 410b5-1 | EW Edwards Lifesciences Corp | Zovighian Bernard J CEO | $428k | 6,164 | |
| 34Weak | sell 510b5-1 | EW Edwards Lifesciences Corp | Ullem Scott B. CVP, Chief Financial Officer | $796k | 11,250 | |
| 32Weak | sell 5 | EW Edwards Lifesciences Corp | LORANGER STEVEN R director | $439k | 5,739 | |
| 37Weak | sell 5 | EW Edwards Lifesciences Corp | STONE HEISZ LESLIE director | $435k | 5,739 | |
| 1Weak | sell 510b5-1 | EW Edwards Lifesciences Corp | Lippis Daniel J. CVP, JAPAC | $38k | 500 | |
| 35Weak | sell 510b5-1 | EW Edwards Lifesciences Corp | Ullem Scott B. CVP, Chief Financial Officer | $852k | 11,250 | |
| 3Weak | sell 210b5-1 | EW Edwards Lifesciences Corp | BOBO DONALD E JR CVP,Strategy/Corp Development | $344k | 5,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.